Company Profile Boards & Staffs Memberships & Partners Academy of Journalism Careers Blog(EN)Contact Us

Our Journals Instruction for Authors Brieflands Policies Publish My Research Journal Management System Article Processing Charges Open Peer Review Publishing Services

Publish My Book

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Current Issue Accepted Manuscripts All Issues In Press Articles Search

Journal Information Boards and committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

Authors Guide Submit Manuscript

Scopus by Title (Ref)

1. Predictive markers for hepatocellular carcinoma development in patients with chronic hepatitis C virus genotype4a

- Zaher E. , et al.

2. Sofosbuvir plus ribavirin for the treatment of chronic genotype 4 hepatitis C virus infection in patients of Egyptian ancestry

- Ruane P.J. , et al.

3. Optimizing treatment for HCV genotype 4: PEG-IFN alfa 2a vs. PEG-IFN alfa 2b; the debate continues

- Esmat G. , et al.

4. HCV genotype 4; A brief review

- Afzal M.S. , et al.

5. How to optimize HCV therapy in genotype 4 patients

- Esmat G. , et al.

6. Frequency and causes of discontinuation of methotrexate in a cohort of Egyptian patients

- El-Zorkany B.K. , et al.

7. Virologic response at week 8 of combined treatment as a predictor of sustained virologic response in non rapid virologic response, chronic HCV genotype 4 infected patients

- Monis A. , et al.

8. Occult hepatitis b virus infection among hemodialysis patients

- Alavian S.M. , et al.